These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12489613)

  • 21. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
    Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-the-counter but out of reach: a pharmacy-based survey of OTC syringe sales in Tijuana, Mexico.
    Pollini RA; Gallardo M; Ruiz S; Case P; Zaller N; Lozada R
    J Health Care Poor Underserved; 2014 May; 25(2):637-51. PubMed ID: 24858873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.
    Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P
    J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
    Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist ambivalence about sale of syringes to injection drug users.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka T; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S52-7. PubMed ID: 12489616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
    Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
    Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
    Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.
    Fuller CM; Galea S; Caceres W; Blaney S; Sisco S; Vlahov D
    Am J Public Health; 2007 Jan; 97(1):117-24. PubMed ID: 17138929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.
    Rose VJ; Lutnick A; Kral AH
    J Psychoactive Drugs; 2014; 46(3):226-32. PubMed ID: 25052881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users.
    Burris S; Welsh J; Ng M; Li M; Ditzler A
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S94-8. PubMed ID: 12489625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community pharmacist perspectives on HIV/AIDS and interventions for injection drug users in Canada.
    Myers T; Cockerill R; Worthington C; Millson M; Rankin J
    AIDS Care; 1998 Dec; 10(6):689-700. PubMed ID: 9924524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002).
    Finkelstein R; Tiger R; Greenwald R; Mukherjee R
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S83-7. PubMed ID: 12489622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse event associated with a change in nonprescription syringe sale policy.
    Zaller ND; Yokell MA; Jeronimo A; Bratberg JP; Case P; Rich JD
    J Am Pharm Assoc (2003); 2010; 50(5):619-22. PubMed ID: 20833621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonprescription syringe sales: a missed opportunity for HIV prevention in California.
    Pollini RA; Rudolph AE; Case P
    J Am Pharm Assoc (2003); 2015; 55(1):31-40. PubMed ID: 25575149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.
    Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
    Am J Public Health; 2013 Sep; 103(9):1579-82. PubMed ID: 23865644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.
    Lutnick A; Case P; Kral AH
    J Urban Health; 2012 Apr; 89(2):354-64. PubMed ID: 22231488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.